Nang Kwang Chemical Pharmaceutical Co., Ltd. Announces 2025 Q4 Earnings Per Share of NT$2.42
NQ Score
53/100
N1 Content Completeness
3
AI Summary (NQ-processed)
Nang Kwang Chemical Pharmaceutical Co., Ltd. (Stock Code: 1752) reported its financial results for the fourth quarter of 2025. The company's operating revenue for the quarter was NT$2.162 billion, with a net profit after tax of NT$244 million, resulting in basic earnings per share of NT$2.42. The company belongs to the biotechnology and healthcare industry.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is Nang Kwang Chemical Pharmaceutical's stock code?
- A: Nang Kwang Chemical Pharmaceutical's stock code is 1752.
- Q: What were Nang Kwang Chemical Pharmaceutical's Q4 2025 financial results?
- A: In Q4 2025, Nang Kwang Chemical Pharmaceutical reported operating revenue of NT$2.162 billion, net profit after tax of NT$244 million, and basic earnings per share of NT$2.42.
- Q: What industry does Nang Kwang Chemical Pharmaceutical belong to?
- A: Nang Kwang Chemical Pharmaceutical belongs to the biotechnology and healthcare industry.